Equinor ASA EQNR
42.19
(0.98)
(2.27%)
as of 25 Sep
- Market cap
- $102.3B
- P/E
- 11.5×
Follow EQNR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
8.56 | 19.36 | 12.37 | 11.50 |
+8 more quarters Free account |
P/S ratio |
0.67 | 1.01 | 0.58 | 0.57 | |
P/FCF ratio |
6.23 | 23.32 | 7.27 | 7.54 | |
P/Operating CF |
8.06 | 20.21 | 29.09 | 9.71 | |
P/B ratio |
1.77 | 2.41 | 1.51 | 1.52 | |
Price to Tangible BV |
2.05 | 2.80 | 1.77 | 1.80 | |
EV/Sales |
0.67 | 1.06 | 0.64 | 0.59 | |
EV/EBITDA |
1.73 | 2.90 | 1.80 | 1.59 | |
EV/Operating CF |
3.32 | 6.82 | 3.40 | 3.23 | |
EV/FCF |
6.27 | 24.40 | 8.05 | 7.87 | |
Quick Ratio |
0.92 | 0.89 | 0.98 | 0.93 | |
Current Ratio |
1.18 | 1.24 | 1.27 | 1.48 | |
Net Debt/EBITDA |
0.03 | 0.43 | 0.75 | 0.31 | |
Debt/Assets |
17.21% | 17.67% | 19.73% | 18.46% | |
Debt/Equity |
0.56 | 0.57 | 0.64 | 0.62 | |
Asset Turnover |
0.82 | 0.77 | 0.81 | 0.80 | |
Operating CF/Net income |
1.95 | 1.68 | 1.60 | (30.22) | |
Capex/Depreciation |
(0.82) | (1.23) | (0.63) | (1.02) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.54% | 0.55% | 1.13% | 0.97% | |
Selling, General and Administrative Expense of Revenue |
0.78% | 1.11% | 1.17% | 0.99% | |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.05 | 0.05 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.69) | (0.49) | (0.85) | (0.70) | |
Graham Number |
38.28 | 29.29 | 25.91 | 27.68 | |
Earnings Yield |
11.69% | 5.17% | 8.08% | 8.70% | |
Free Cash Flow Yield |
16.06% | 4.29% | 13.76% | 13.26% | |
Revenue per Share |
14.47 | 11.16 | 9.78 | 10.31 | |
Operating CF per Share |
3.90 | 2.09 | 0.81 | 2.51 | |
Capex per Share |
(0.92) | (1.25) | (0.82) | (1.35) | |
Free Cash Flow per Share |
2.98 | 0.84 | 0.00 | 1.16 | |
Cash per Share |
9.76 | 8.05 | 7.46 | 8.86 | |
Shareholders Equity per Share |
17.74 | 17.48 | 15.62 | 16.06 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
17.74 | 17.48 | 15.62 | 16.06 | |
Free Cash Flow |
7,244.00 | 2,097.00 | (8.00) | 2,927.00 | |
Working Capital |
6,806.00 | 8,858.00 | 8,160.00 | 16,946.00 | |
Capital Expenditures |
(2,226.00) | (3,116.00) | (2,114.00) | (3,420.00) | |
Net Current Asset Value |
(52,335.00) | (51,606.00) | (52,290.00) | (43,101.00) | |
EV/EBIT |
2.36 | 4.36 | 2.68 | 2.25 | |
Capex to Sales |
0.06 | 0.11 | 0.08 | 0.13 | |
Net Profit Margin |
13.78% | 11.16% | 5.18% | (0.81%) | |
Price to Operating Income |
2.35 | 4.17 | 2.42 | 2.15 | |
| Other line items | |||||
Average Receivables |
11,659.00 | 11,850.50 | 12,204.50 | 10,474.50 | |
Average Payables |
10,720.00 | 10,537.00 | 10,405.00 | 9,795.50 | |
Average Inventory |
3,372.50 | 3,784.50 | 3,680.50 | 3,497.00 | |
Average Assets |
139,995.00 | 136,440.50 | 131,434.00 | 135,481.50 | |
Average Common Equity |
42,552.50 | 42,069.00 | 41,438.50 | 42,489.00 |
Columns are period end dates